Sort

Search

01/09/2021 Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease
De Paepe, AE, Ara, A, Garcia-Gorro, C, Martinez-Horta, S, Perez-Perez, J, Kulisevsky, J, Rodriguez-Dechicha, N, Vaquer, I, Subira, S, Calopa, M, Munoz, E, Santacruz, P, Ruiz-Idiago, J, Mareca, C, de Diego-Balaguer, R, Camara, E. Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease. MOVEMENT DISORDERS. 2021; 36(9)DOI:10.1002/mds.28638. PMID:33998063. IF:9.698(Q1/1D).
01/09/2021 Moderators of cognitive insight outcome in metacognitive training for first-episode psychosis
Gonzalez-Blanch, C, Birules, I, Pousa, E, Barrigon, ML, Lopez-Carrilero, R, Lorente-Rovira, E, Ayesa-Arriola, R, Setien-Suero, E, Barajas, A, Grasa, EM, Ruiz-Delgado, I, Gonzalez-Higueras, F, Cid, J, Ochoa, S. Moderators of cognitive insight outcome in metacognitive training for first-episode psychosis. JOURNAL OF PSYCHIATRIC RESEARCH. 2021; 141DOI:10.1016/j.jpsychires.2021.06.040. PMID:34186271. IF:5.250(Q2/4D).
01/09/2021 The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory
Ballesteros, A, Torres, AMS, Lopez-Ilundain, J, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Pina-Camacho, L, Corripio, I, Vieta, E, de la Serna, E, Mane, A, Bioque, M, Moreno-Izco, L, Espliego, A, Lorente-Omenaca, R, Amoretti, S, Bernardo, M, Cuesta, MJ. The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory. PSYCHOLOGICAL MEDICINE. 2021; 51(12)DOI:10.1017/S003329172000080X. PMID:32326991. IF:10.592(Q1/1D).
01/09/2021 Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain
Pascual, JC, Martin-Blanco, A, Soler, J. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain. CNS DRUGS. 2021; 35(9)DOI:10.1007/s40263-021-00852-7. PMID:34370282. IF:6.497(Q1/2D).